ALT Stock Analysis: Buy, Sell, or Hold?
ALT - Altimmune, Inc. Common Stock
$2.91
-0.02 (-0.68%)
▼
5d:
+10.23%
30d:
-0.68%
90d:
-15.41%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When ALT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called ALT this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ALT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: ALT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: ALT is currently trading at $2.91, which is considered slightly high relative to its 30-day fair value range of $2.67 to $2.96.
Technical Outlook: Technically, ALT is in a strong downtrend. Immediate support is located at $2.57, while resistance sits at $3.04.
Market Sentiment: ALT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.45 (+430.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ALT is in a strong downtrend. Immediate support is located at $2.57, while resistance sits at $3.04.
Market Sentiment: ALT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.45 (+430.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.67 -
$2.96
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 430.9% below Wall St target ($15.45)
Trading Range Analysis
30-Day Trading Range
$2.67 -
$2.96
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.57
Resistance Level
$3.05
Current Trend
Strong Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.39
Wall Street Target
$15.45
(+430.9%)
Revenue Growth (YoY)
420.0%
Share & Embed Analysis
Last updated: June 24, 2026 1:25 AM ET
Data refreshes hourly during market hours. Next update: 2:25 AM
Data refreshes hourly during market hours. Next update: 2:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALT showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Gregory L Weaver
BUY
5000 shares
2026-03-06
Jerome Benedict Durso
BUY
20000 shares
2026-03-06
Wayne Pisano
BUY
5000 shares
2026-01-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 64 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 62 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 65 BUY |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 63 BUY |
